Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge.

Using microarrays, the authors independently analysed PTEN–Akt–mTOR and Erk–MAPK signalling pathways ... who showed that treatment with a dual mTOR and PI3K inhibitor, PI-103, in combination ...